With a new method to synthesize DNA, San Diego's Molecular Assemblies notches $24M Series A
A San Diego biotech is taking a closer look at the way synthetic DNA is engineered, aiming to potentially revamp the decades-old process and serve as a partner to companies without the resources to create the DNA themselves.
And now they have significant investor backing to do so. Molecular Assemblies closed an oversubscribed Series A on Thursday morning, locking down $24 million in the round to advance their synthetic biology platform.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.